Ausgabe 3/2022
Inhalt (21 Artikel)
miRNAs as therapeutic predictors and prognostic biomarkers of neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
Zhuo Zhang, Hanxu Zhang, Jiao Yu, Ling Xu, Xiaocong Pang, Qian Xiang, Qianxin Liu, Yimin Cui
Allogeneic hematopoietic cell transplantation in patients with a hematologic malignancy and a prior history of breast cancer
Kristine Doney, Wendy Leisenring, Hannah Linden
Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer
Lili Chen, Yanyang Chen, Zhongpeng Xie, Jiao Luo, Yuefeng Wang, Jianwen Zhou, Leilei Huang, Hongxia Li, Linhai Wang, Pei Liu, Man Shu, Wenhui Zhang, Zunfu Ke
Tumor-associated mononuclear cells in the tumor bed of triple-negative breast cancer associate with clinical outcomes in the post-neoadjuvant chemotherapy setting
Thaer Khoury, Saif Aljabab, Song Yao, Christine Ambrosone, Angela Omilian, Kristopher Attwood, Wenyan Ji, Shipra Gandhi
Awareness of link between obesity and breast cancer risk is associated with willingness to participate in weight loss intervention
Laura Burkbauer, Macy Goldbach, Cassie Huang, Julia Lewandowski, Robert Krouse, Kelly Allison, Julia Tchou
Co-occurrence and metabolic biomarkers of sensory and motor subtypes of peripheral neuropathy from paclitaxel
Ciao-Sin Chen, Ellen M. Lavoie Smith, Kathleen A. Stringer, N. Lynn Henry, Daniel L. Hertz
Risk of secondary malignancy after radiotherapy for breast cancer: long-term follow-up of Japanese patients with breast cancer
Noriyuki Okonogi, Kumiko Karasawa, Yuki Nitta, Yasumasa Mori, Kazutoshi Murata, Masaru Wakatsuki, Hiroshi Tsuji
Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer
Neelima Vidula, Christina Yau, Hope Rugo
The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer
Ida Skarping, Kristoffer Nilsson, Looket Dihge, Adam Fridhammar, Mattias Ohlsson, Linnea Huss, Pär-Ola Bendahl, Katarina Steen Carlsson, Lisa Rydén
Clinical utility of MRI in the neoadjuvant management of early-stage breast cancer
L. Corke, L. Luzhna, K. Willemsma, C. Illmann, M. Mcdermott, C. Wilson, C. Simmons, N. LeVasseur
Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis
Tal Sella, Pedro Exman, Siyang Ren, Taylor S. Freret, Katherine E. Economy, Wendy Y. Chen, Heather A. Parsons, Nancy U. Lin, Beverly Moy, Nadine M. Tung, Ann H. Partridge, Nabihah Tayob, Erica L. Mayer
Decision quality and regret with treatment decisions in women with breast cancer: Pre-operative breast MRI and breast density
Karen J. Wernli, Rebecca E. Smith, Louise M. Henderson, Wenyan Zhao, Danielle D. Durham, Karen Schifferdecker, Celia Kaplan, Diana S. M. Buist, Karla Kerlikowske, Diana L. Miglioretti, Tracy Onega, Nila H. Alsheik, Brian L. Sprague, Gloria Jackson-Nefertiti, Jill Budesky, Dianne Johnson, Anna N. A. Tosteson
Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence
R. Haarsma, A. A. van Loevezijn, M. L. Donswijk, A. N. Scholten, M. T. F. D. Vrancken Peeters, F. H. van Duijnhoven
Long-term survival in elderly women receiving chemotherapy for non-metastatic breast cancer: a population-based analysis
Matthew Castelo, Justin Lu, Lawrence Paszat, Zachary Veitch, Kuan Liu, Adena S. Scheer
Racial and ethnic disparities in the refusal of surgical treatment in women 40 years and older with breast cancer in the USA between 2010 and 2017
Pierre Fwelo, Zenab I. Yusuf, Abigail Adjei, Gabriel Huynh, Xianglin L. Du
The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy
Tal Sella, Olga Kantor, Anna Weiss, Ann H. Partridge, Otto Metzger, Tari A. King
Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations
Ashley M. Geczik, Jennifer S. Ferris, Mary Beth Terry, Irene L. Andrulis, Saundra S. Buys, Mary B. Daly, John L. Hopper, Esther M. John, Allison W. Kurian, Melissa C. Southey, Yuyan Liao, Jeanine M. Genkinger
Surgical margin status and survival outcomes of breast cancer patients treated with breast-conserving surgery and whole-breast irradiation after neoadjuvant chemotherapy
Jong-Ho Cheun, Young Joo Lee, Jun-Hee Lee, Yungil Shin, Jung Whan Chun, Soo Yeon Baek, Hong-Kyu Kim, Han-Byoel Lee, Jonghan Yu, Byung Joo Chae, Wonshik Han, Jeong Eon Lee
Surveillance mammography after treatment for male breast cancer
Siddhartha Yadav, Lindsey Sangaralingham, Stephanie R. Payne, Karthik V. Giridhar, Tina J. Hieken, Judy C. Boughey, Robert W. Mutter, John R. Hawse, Rafael E. Jimenez, Rachel A. Freedman, Sadia Khanani, Fergus J. Couch, Celine Vachon, Nilay Shah, Roberto A. Leon-Ferre, Kathryn J. Ruddy
A mixed method study of medical oncologists’ perceived barriers and motivators to addressing long-term effects in breast cancer survivors
Alex J. Fauer, Patricia A. Ganz, Eden R. Brauer
Comment on “Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta‑analysis”
Francesca Poggio, Marcello Ceppi, Piero Fregatti, Matteo Lambertini, Marco Tagliamento